Day: February 11, 2026

Senti Biosciences Completes Enrollment in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia (R/R AML)

Robust SENTI-202 clinical data presented at ASH 2025 demonstrated deep, MRD-negative, durable complete remissions and a favorable safety profile Company...

Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq Requirements

Aspire Biopharma Announces $21 Million Private Placement by Select Investors, Strengthening Balance Sheet, Capital Position, and Fortifying Shareholder Equity to Meet Nasdaq Requirements

Black Book Research Releases “Brazil Acute Care EHR and Digital Health 2026” Report Highlighting RNDS Interoperability, AI Governance Readiness, and Cyber-Resilient Hospital Modernization

Black Book Research Releases “Brazil Acute Care EHR and Digital Health 2026” Report Highlighting RNDS Interoperability, AI Governance Readiness, and Cyber-Resilient Hospital Modernization

VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego

Company produces thorough reference testing on Antibody Drug Conjugates, showing high correlation with clinical liver and intestinal toxicity and side...

Robert A. Winn Excellence in Clinical Trials Award Program Announces Third Cohort of Physician-Researchers for the Clinical Investigator Leadership Award

Bristol Myers Squibb Foundation is proud to support Conquer Cancer's EveryGrant and the American Heart Association to Advance Clinical Trials...

Robert A. Winn Excellence in Clinical Trials Award Program Announces Third Cohort of Physician-Researchers for the Clinical Investigator Leadership Award

Bristol Myers Squibb Foundation is proud to support Conquer Cancer's EveryGrant and the American Heart Association to Advance Clinical Trials...

error: Content is protected !!